Bolli R., Cannon RO., Speir E., Goldstein RE., Epstein SE. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo. J Am Coll Cardiol. 2:671–680. 1983.
Article
Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int. 43:1160–1178. 1993.
Article
Borkan SC., Schwartz JH. Role of oxygen free radical species in in vitro models of proximal tubular ischemia. Am J Physiol. 257:F114–F125. 1989.
Article
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976.
Article
Bunnachak D., Almeida AR., Wetzels JF., Gengaro P., Nemenoff RA., Burke TJ., Schrier RW. Ca2+ uptake, fatty acid, and LDH release during proximal tubule hypoxia: effects of mepacrine and dibucaine. Am J Physiol. 266:F196–F201. 1994.
Chatterjee PK., Todorovic Z., Sivarajah A., Mota-Filipe H., Brown PA., Stewart KN., Mazzon E., Cuzzocrea S., Thiemermann C. Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury. Biochem Pharmacol. 69:1121–1131. 2005.
Article
Choi KH., Edelstein CL., Gengaro P., Schrier RW., Nemenoff RA. Hypoxia induces changes in phospholipase A2 in rat proximal tubules: evidence for multiple forms. Am J Physiol. 269:F846–F853. 1995.
Choi WR., Ko SH., Cho SI., Woo JS., Jung JS., Lee SH., Kim YK. Role of phospholipase A2 in hypoxia-induced renal cell injury. Korean J Physiol Pharmacol. 3:93–100. 1999.
Dagher PC. Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. Am J Physiol Cell Physiol. 279:C1270–1277. 2000.
Article
Denis I., Pointillart A., Lieberherr M. Effects of growth hormone and insulin-like growth factor-I on the proliferation and differentiation of cultured pig bone cells and rat calvaria cells. Growth Regul. 4:123–130. 1994.
Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 17:1503–1520. 2006.
Article
Devarajan P., Mishra J., Supavekin S., Patterson LT., Steven Potter S. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 80:365–376. 2003.
Article
Edelstein CL., Ling H., Schrier RW. The nature of renal cell injury. Kidney Int. 51:1341–1351. 1997.
Article
Frangie C., Zhang W., Perez J., Dubois YC., Haymann JP., Baud L. Extracellular calpains increase tubular epithelial cell mobility. Implications for kidney repair after ischemia. J Biol Chem. 281:26624–26632. 2006.
Goll DE., Thompson VF., Li H., Wei W., Cong J. The calpain system. Physiol Rev. 83:731–801. 2003.
Article
Gores GJ., Flarsheim CE., Dawson TL., Nieminen AL., Herman B., Lemasters JJ. Swelling, reductive stress, and cell death during chemical hypoxia in hepatocytes. Am J Physiol. 257:C347–354. 1989.
Article
Gores GJ., Nieminen AL., Fleishman KE., Dawson TL., Herman B., Lemasters JJ. Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. Am J Physiol. 255:C315–322. 1988.
Article
Gores GJ., Nieminen AL., Wray BE., Herman B., Lemasters JJ. Intracellular pH during “chemical hypoxia” in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J Clin Invest. 83:386–396. 1989.
Article
Goto S., Nakamura H., Morooka H., Terao Y., Shibata O., Sumikawa K. Role of reactive oxygen in phospholipase A2 activation by ischemia/reperfusion of the rat kidney. J Anesth. 13:90–93. 1999.
Habib MM., Hodgson HJ., Davidson BR. The role of glycine in hepatic ischemia-reperfusion injury. Curr Pharm Des. 12:2953–2967. 2006.
Article
Hagar H., Ueda N., Shah SV. Role of reactive oxygen metabolites in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Am J Physiol. 271:F209–F215. 1996.
Article
Halliwell B., Gutteridge JMC., Cross CE. Free radicals, antioxidants, and human disease: Where are we now? J Lab Clin Med. 119:598–620. 1992.
Humes HD., Nguyen VD., Cieslinski DA., Messana JM. The role of free fatty acids in hypoxia-induced injury to renal proximal tubule cells. Am J Physiol. 256:F688–696. 1989.
Article
Joannidis M., Gstraunthaler G., Pfaller W. Xanthine oxidase: evidence against a causative role in renal reperfusion injury. Am J Physiol. 258:F232–236. 1990.
Article
Kim SY., Kim CH., Yoo HJ., Kim YK. Effects of radical scavengers and antioxidant on ischemic acute renal failure in rabbits. Renal Failure. 21:1–11. 1999.
Article
Kim YK., Lee SK., Ha MS., Woo JS., Jung JS. Differential role of reactive oxygen species in chemical hypoxia-induced cell injury in opossum kidney cells and rabbit renal cortical slices. Exp Nephrol. 10:275–284. 2002.
Article
Lash LH., Tokarz JJ., Chen Z., Pedrosi BM., Woods EB. ATP depletion by iodoacetate and cyanide in renal distal tubular cells. J Pharmacol Exp Ther. 276:194–205. 1996.
Lash LH., Tokarz JJ., Chen Z., Pedrosi BM., Woods EB. ATP depletion by iodoacetate and cyanide in renal distal tubular cells. J Pharmacol Exp Ther. 276:194–205. 1996.
Liu X., Harriman JF., Schnellmann RG. Cytoprotective properties of novel nonpeptide calpain inhibitors in renal cells. J Pharmacol Exp Ther. 302:88–94. 2002.
Article
Liu X., Rainey JJ., Harriman JF., Schnellmann RG. Calpains mediate acute renal cell death: role of autolysis and translocation. Am J Physiol Renal Physiol. 281:F728–738. 2001.
Article
Matthys E., Patel Y., Kreisberg J., Stewart JH., Venkatachalam M. Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage. Kidney Int. 26:153–161. 1984.
Article
Nakamura H., Nemenoff RA., Gronich JH., Bonventre JV. Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion. J Clin Invest. 87:1810–1818. 1991.
Nangaku M., Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med. 85:1325–1330. 2007.
Article
Nicotera P., McConkey DJ., Dypbukt JM., Jones DP., Orrenius S. Ca2+-activated mechanisms in cell killing. Drug Metab Rev. 20:193–201. 1989.
Nieminen AL., Gores GJ., Bond JM., Imberti R., Herman B., Lemasters JJ. A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol Appl Pharmacol. 115:147–155. 1992.
Article
Nistico R., Piccirilli S., Cucchiaroni ML., Armogida M., Guatteo E., Giampa C., Fusco FR., Bernardi G., Nistico G., Mercuri NB. Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol. 153:1022–1029. 2008.
Paller MS. The cell biology of reperfusion injury in the kidney. J Investi Med. 42:632–639. 1994.
Pan C., Bai X., Fan L., Ji Y., Li X., Chen Q. Cytoprotection by glycine against ATP-depletion-induced injury is mediated by glycine receptor in renal cells. Biochem J. 390:447–453. 2005.
Article
Portilla D., Creer MH. Plasmalogen phospholipid hydrolysis during hypoxic injury of rabbit proximal tubules. Kidney Int. 47:1087–1094. 1995.
Article
Portilla D., Mandel LJ., Bar-Sagi D., Millington DS. Anoxia induces phospholipase A2 activation in rabbit renal proximal tubules. Am J Physiol. 262:F354–360. 1992.
Portilla D., Shah SV., Lehman PA., Creer MH. Role of cytosolic calcium-independent plasmalogen-selective phospholipase A2 in hypoxic injury to rabbit proximal tubules. J Clin Invest. 93:1609–1615. 1994.
Schnellmann RG., Yang X., Carrick JB. Arachidonic acid release in renal proximal tubule cell injuries and death. J Biochem Toxicol. 9:211–217. 1994.
Article
Seyfried DM., Veyna R., Han Y., Li K., Tang N., Betts RL. Weinsheimer S, Chopp M, Anagli J. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res. 901:94–101. 2001.
Street IP., Lin HK., Laliberte F., Ghomashchi F., Wang Z., Perrier H., Tremblay NM., Huang Z., Weech PK., Gelb MH. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry. 32:5935–5940. 1993.
Wang H., Harrison SD., Lemasters JJ., Herman B. Contribution of pH-dependent group II phospholipase A2 to chemical hypoxic injury in rat hepatocytes. FASEB J. 10:1319–1325. 1996.
Watabe M., Nakaki T. ATP depletion does not account for apoptosis induced by inhibition of mitochondrial electron transport chain in human dopaminergic cells. Neuropharmacology. 52:536–541. 2007.
Article
Weinberg JM. The cell biology of ischemic renal injury. Kidney Int. 39:476–500. 1991.
Article
Weinberg JM., Davis JA., Abarzua M., Rajan T. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest. 80:1446–1454. 1987.
Article
Wetzels JF., Wang X., Gengaro PE., Nemenoff RA., Burke TJ., Schrier RW. Glycine protection against hypoxic but not phospholipase A2-induced injury in rat proximal tubules. Am J Physiol. 264:F94–F99. 1993.
Wetzels JF., Yu L., Wang X., Kribben A., Burke TJ., Schrier RW. Calcium modulation and cell injury in isolated rat proximal tubules. J Pharmacol Exp Ther. 267:176–180. 1993.
Yang X., Schnellmann RG. Proteinases in renal cell death. J Toxicol Environ Health. 48:319–332. 1996.
Article
Yin M., Zhong Z., Connor HD., Bunzendahl H., Finn WF., Rusyn I., Li X., Raleigh JA., Mason RP., Thurman RG. Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo. Am J Physiol Renal Physiol. 282:F417–423. 2002.
Zager RA., Burkhart KM., Conrad DS., Gmur DJ., Iwata M. Phospholipase A2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury. J Am Soc Nephrol. 7:64–72. 1996.
Zager RA., Johnson AC., Lund S., Randolph-Habecker J. Toll-like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol. 292:F304–312. 2007.
Article
Zager RA., Schimpf BA., Gmur DJ., Burke TJ. Phospholipase A2 activity can protect renal tubules from oxygen deprivation injury. Proc Natl Acad Sci USA. 90:8297–8301. 1993.
Zhong Z., Wheeler MD., Li X., Froh M., Schemmer P., Yin M., Bunzendaul H., Bradford B., Lemasters JJ. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 6:229–240. 2003.
Article